Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 4
340
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Stimulating effects of vardenafil, tadalafil, and udenafil on vascular endothelial growth factor, angiogenesis, vitamin D3, bone morphogenic proteins in ovariectomized rats

, , , &
Pages 1121-1127 | Received 11 Mar 2020, Accepted 09 Apr 2020, Published online: 21 Apr 2020

References

  • Alp, H.H., et al., 2017. The effect of PDE5 inhibitors on bone and oxidative damage in ovariectomy-induced osteoporosis. Experimental biology and medicine, 242 (10), 1051–1061.
  • Amirian, J., et al., 2015. Bone formation of a porous gelatin-pectin-biphasic calcium phosphate composite in presence of BMP-2 and VEGF. International journal of biological macromolecules, 76, 10–24.
  • Bajraktari, G., et al., 2017. Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets. Biochemical pharmacology, 145, 54–63.
  • Calcei, J.G., and Rodeo, S.A., 2019. Orthobiologics for bone healing. Clinics in sports medicine, 38 (1), 79–95.
  • Cardus, A., et al., 2006. 1,25-dihydroxyvitamin D-3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney international, 69 (8), 1377–1384.
  • Carreira, A.C., et al., 2014. Bone morphogenetic proteins: structure, biological function and therapeutic applications. Archives of biochemistry and biophysics, 561, 64–73.
  • Chen, R., et al., 2018. Tuning the bioactivity of bone morphogenetic protein-2 with surface immobilization strategies. Acta biomaterialia, 80, 108–120.
  • Cho, Y.S., et al., 2018. Effects of renal impairment on the pharmacokinetics and safety of udenafil. The journal of clinical pharmacology, 58 (7), 905–912.
  • Comba, A., et al., 2015. Effect of sildenafil citrate on MDA, GSH, retinol, vitamin D3 and α-tocoferole levels in wound healing: diabetic rat model. Journal of applied biological sciences, 9 (3), 82–85.
  • D’Andrea, S., et al., 2019. Effect of prolonged treatment with phosphodiesterase‐5‐inhibitors on endothelial dysfunction in vascular diseases and vascular risk conditions: a systematic review analysis and meta‐analysis of randomized double‐blind placebo‐controlled trials. International journal of clinical practice, 73, e13296.
  • Deckers, M.M.L., et al., 2002. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology, 143 (4), 1545–1553.
  • Eğri, S., and Eczacıoğlu, N., 2017. Sequential VEGF and BMP-2 releasing PLA-PEG-PLA scaffolds for bone tissue engineering: I. Design and in vitro tests. Artifical cells nanomedicine and biotechnology, 45 (2), 321–329.
  • Er, E.Ö., et al., 2019. Accurate and sensitive determination of sildenafil, tadalafil, vardenafil, and avanafil in illicit erectile dysfunction medications and human urine by LC with quadrupole-TOF-MS/MS and their behaviors in simulated gastric conditions. Journal of separation science, 42 (2), 475–483.
  • Haubruck, P., et al., 2016. The treatment of nonunions with application of BMP-7 increases the expression pattern for angiogenic and inflammable cytokines: a matched pair analysis. Journal of inflammation research, 9, 155–165.
  • Huang, H.M., et al., 2016. Effects of roughly focused extracorporeal shock waves therapy on the expressions of bone morphogenetic protein‑2 and osteoprotegerin in osteoporotic fracture in rats. Chinese medical journal, 129 (21), 2567–2575.
  • Huang, Y.C., et al., 2004. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. Journal of bone and mineral research, 20 (5), 848–857.
  • Huyut, Z., et al., 2018. Effects of the phosphodiesterase-5 (PDE-5) inhibitors, avanafil and zaprinast, on bone remodeling and oxidative damage in a rat model of glucocorticoid-induced osteoporosis. Medical science monitor basic research, 24, 47–58.
  • Huyut, Z., et al., 2020. Can zaprinast and avanafil induce the levels of angiogenesis, bone morphogenic protein 2, 4 and 7 in kidney of ovariectomized rats? Archives of physiology and biochemistry, 1–6. doi:https://doi.org/10.1080/13813455.2020.1740743
  • Imai, Y., et al., 2018. Sildenafil ameliorates right ventricular early molecular derangement during left ventricular pressure overload. Plos one, 13 (4), e0195528.
  • Kanayama, S., et al., 2018. ONO-1301 enhances in vitro osteoblast differentiation and in vivo bone formation induced by bone morphogenetic protein. Spine, 43 (11), 616–624.
  • Kim, H.S., et al., 2018. Effects of 1,25-dihydroxyvitamin D3 on the differentiation of MC3T3-E1 osteoblast-like cells. Journal of periodontal & implant science, 48 (1), 34–46.
  • Koka, S., et al., 2020. Chronic inhibition of phosphodiesterase 5 with tadalafil affords cardioprotection in a mouse model of metabolic syndrome: role of nitric oxide. Molecular and cellular biochemistry, 468 (1–2), 47–12.
  • Liao, H., et al., 2017. Bone mesenchymal stem cells co‑expressing VEGF and BMP‑6 genes to combat avascular necrosis of the femoral head. Experimental and therapeutic medicine, 15, 954–962.
  • Liu, X., et al., 2018. BMP9 overexpressing adipose‑derived mesenchymal stem cells promote cartilage repair in osteoarthritis-affected knee joint via the Notch1/Jagged1 signaling pathway. Experimental and therapeutic medicine, 16, 4623–4631.
  • Mancini, N., et al., 2000. The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent. Biochemical and biophysical research communications, 274 (2), 477–481.
  • Mao, F., et al., 2020. The phosphodiesterase-5 inhibitor vardenafil improves the activation of BMP signaling in response to hydrogen peroxide. Cardiovascular drugs and therapy, 34 (1), 41–52.
  • Pal, S., et al., 2020. Skeletal restoration by phosphodiesterase 5 inhibitors in osteopenic mice: evidence of osteoanabolic and osteoangiogenic effects of the drugs. Bone, 135, 115305.
  • Pepe, J., et al., 2017. The effect of parathyroid hormone (1–84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis. Journal of endocrinological investigation, 40 (6), 663–667.
  • Ramos, R.D.G., et al., 2018. Use of bone morphogenetic protein-2 in vertebral column tumor surgery: a national investigation. World neurosurgery, 117, e17–e21.
  • Schlaeppi, J.M., et al., 1997. 1,25-dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocrine research, 23 (3), 213–229.
  • Shi, S. R., et al., 1996. A novel approach to immunohistochemistry on routinely processed tissue sections. In: J. Gu ed. Analitical morphology theory, applications and protocols. 1st ed. Basel, Switzerland: Birkhauser, 1–40.
  • Wang, L., et al., 2016. Tadalafil promotes the recovery of peripheral neuropathy in type II diabetic mice. Plos one, 11 (7), e0159665.
  • Wang, W., et al., 2016. A fucoidan from Nemacystus decipiens disrupts angiogenesis throughtargeting bone morphogenetic protein 4. Carbohydrate polymers, 144, 305–314.
  • Wang, X., et al., 2018. Alteration of bone mineral density differs between genders in obese subjects after laparoscopic sleeve gastrectomy: bone morphogenetic protein 4 may count. Obesity surgery, 28 (10), 3221–3226.
  • Yaman, F., et al., 2011. Phosphodiesterase-5 inhibitors may facilitate bone defect recovery. European review for medical and pharmacological sciences, 15 (11), 1301–1305.
  • Zhou, N., et al., 2016. BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells. Cell and tissue research, 366 (1), 101–111.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.